EURO-VOYAGE: Effectiveness and safety of ipilimumab (IPI) administered during a European Expanded Access Programme (EAP) in patients with advanced melanoma (MEL)Paolo A. Ascierto, C.U. Blank, Anders Ekbom et al.|European Journal of Cancer|2017Cited by 3